{
  "docId": "019dd923-622c-750b-8b9a-21918ac10c17",
  "docSlug": "f3db2294dcf9",
  "documentTitle": "Harmony Biosciences (HRMY)",
  "authorId": "58_Scorpion_Capital",
  "authorName": "Scorpion Capital",
  "documentKindSlug": "research-note",
  "documentKindLabel": "Research note",
  "sourceTypeSlug": "short_seller",
  "sourceTypeLabel": "Short seller",
  "presentationDate": "2023-03-28 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.3333334,
  "pageNumber": 71,
  "pageCount": 366,
  "prevPage": 70,
  "nextPage": 72,
  "slideType": "research-note",
  "function": "diagnose_problem",
  "density": "dense",
  "nDataPoints": 12,
  "notes": "The slide uses a combination of chemical structure diagrams, a tabular summary of clinical trial failures, and a pie chart showing the distribution of indications for failed trials.",
  "elementsJson": [
    "paragraph",
    "data_table",
    "pie_chart",
    "footnote"
  ],
  "metadataConfidence": 0.95,
  "imagePath": null,
  "slideHref": "/slides/019dd923-622c-750b-8b9a-21918ac10c17/71",
  "deckHref": "/decks/019dd923-622c-750b-8b9a-21918ac10c17",
  "deckJsonHref": "/decks/019dd923-622c-750b-8b9a-21918ac10c17.json",
  "deckAnchorHref": "/decks/019dd923-622c-750b-8b9a-21918ac10c17#slide-71",
  "components": [
    {
      "bbox": null,
      "kind": "callout",
      "text": "For example, it shows that Abbot, J&J, Merck, Pfizer, and others all tried and failed in their H3R programs for narcolepsy and excessive daytime sleepiness.",
      "attrs": null,
      "subkind": null,
      "toolName": "Visual emphasis",
      "toolSlug": "visual-emphasis",
      "confidence": null,
      "componentId": "019dd953-64d0-7099-9cce-40813bf02c3f",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.22,
        "w": 0.42,
        "x": 0.51,
        "y": 0.72
      },
      "kind": "chart",
      "text": "Pie chart showing distribution of clinical trial indications",
      "attrs": null,
      "subkind": "pie",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "6a6e2f4a-eb2e-47b9-a4a3-39f307638cf1",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.45,
        "w": 0.42,
        "x": 0.07,
        "y": 0.45
      },
      "kind": "image",
      "text": "Chemical structures of various H3R antagonists",
      "attrs": null,
      "subkind": "illustration",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "c1531b8a-3313-4be6-a488-258b7a903a98",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.25,
        "w": 0.86,
        "x": 0.07,
        "y": 0.07
      },
      "kind": "paragraph",
      "text": "The paper is one of many reviews in the H3 receptor antagonist/inverse agonist literature that documents the long list of failed pharma programs. It shows the various flavors of H3 drug candidates that each company attempted; the countless indications they tried for each candidate; and summarizes the failed clinical trials for every condition under the sun: sleep disorders like narcolepsy, allergies, ADHD, dementia, schizophrenia, pain, obesity, multiple sclerosis, etc.. For example, it shows that Abbot, J&J, Merck, Pfizer, and others all tried and failed in their H3R programs for narcolepsy and excessive daytime sleepiness.",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "d787a975-959c-461c-9468-7edc755ac96d",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.02,
        "w": 0.25,
        "x": 0.07,
        "y": 0.95
      },
      "kind": "source-note",
      "text": "Source: https://pubmed.ncbi.nlm.nih.gov/31028835/",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "0d5d8db4-2b80-4276-8c00-303134ef9886",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.25,
        "w": 0.42,
        "x": 0.51,
        "y": 0.45
      },
      "kind": "table",
      "text": "Table of H3R drug programs by company, compound, status, phase, trial ID, and indication",
      "attrs": null,
      "subkind": "data",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "da9a07eb-3d43-4f7f-ae65-a0c7f4783d33",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.06,
        "w": 0.42,
        "x": 0.51,
        "y": 0.37
      },
      "kind": "title",
      "text": "Small excerpt of table showing H3R drug programs by pharma company and indication, as well a pie chart of attempted clinical trials",
      "attrs": null,
      "subkind": "subtitle",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "c91e5861-95b3-4692-b830-33c9004cc57b",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.06,
        "w": 0.42,
        "x": 0.07,
        "y": 0.37
      },
      "kind": "title",
      "text": "Table of chemical structures of H3R antagonists/inverse agonists by Pfizer, Merck, Glaxo, Abbot, Astra Zeneca, and others",
      "attrs": null,
      "subkind": "subtitle",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "eff660a6-e64b-416d-b407-2353197f9caf",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}